Carlyle Acquires Majority Stake in Knack and Equalize to Form AI-Driven Healthcare RCM Platform

Carlyle has acquired majority stakes in Knack RCM and EqualizeRCM, US-based healthcare revenue cycle management providers. The combined platform will enhance AI capabilities and broaden operational scale. Equity comes from Carlyle Asia Partners funds. Knack and Equalize will enhance healthcare outcomes by integrating analytics and global operations.

Global investment firm Carlyle has announced its acquisition of a majority stake in Knack RCM and EqualizeRCM, two prominent US healthcare revenue cycle management companies. Leveraging its equity from Carlyle Asia Partners funds, the firm aims to craft an AI-native, global, multi-specialty RCM platform.

Both Knack and Equalize bring complementary strengths in healthcare RCM services, serving a spectrum of providers, from physician groups to rural hospitals. Their merger is designed to amplify operational scale, diversify service offerings, and enhance leadership capabilities, eventually boosting client outcomes through advanced AI integration.

Carlyle's strategy underscores the firm's ambition to create a scalable, strategic RCM platform tailored to align with the shifting paradigms in U.S. healthcare, notably the movement toward value-based care. This positions them to meet increasing demand in the sector effectively.